Results per Page:
Novel regimen greatly reduced chronic GVHD in phase 2 study at Fred Hutch
Substituting cyclophosphamide for a standard post-transplant immunosuppressant is a “gamechanger”
Testing cord blood transplants as a cure for leukemia — and HIV
New clinical trial at several U.S. cancer centers will enroll people living with HIV and advanced leukemia
T cell diversity as a measure of immune recovery following CBT
From the Cord Blood Group and colleagues, Clinical Research Division
Study aims to cure blood cancers with transplants that could block HIV, too
10 HIV-positive cancer patients to receive donated cord blood with rare resistance gene
Good News: Kleberg Foundation grant to support clinical trial for leukemia patients
Celebrating faculty and staff achievements
Umbilical cord blood transplant linked to lower relapse in high-risk leukemia patients
Study compares ‘alternative’ donor source vs. traditional transplantation of blood stem cells from an adult, unrelated donor